Sunshine Biopharma Inc (SBFM) Total Assets by Year
Sunshine Biopharma Inc closed fiscal year 2025 with $30.1M in total assets, $7.0M in total liabilities and $23.0M in shareholder equity. This represents a decrease of 1.6% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Sunshine Biopharma Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SBFM Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.1M-1.6% | $30.6M+11.8% | $27.3M-6.5% | $29.2M+1227.5% | $2.2M+110.7% | $1.0M+965.3% | $98K-91.4% | $1.1M+345.3% | $257K+299.8% | $64K-90.4% | $673K+369.4% | $143K+359.1% | $31K-76.8% | $135K+26.6% | $106K |
| Total Liabilities | $7.0M-0.3% | $7.1M+15.0% | $6.1M-19.4% | $7.6M+282.5% | $2.0M-0.5% | $2.0M+140.0% | $834K-30.7% | $1.2M+44.7% | $831K+203.1% | $274K-78.4% | $1.3M+139.2% | $531K+1263.3% | $39K-39.5% | $64K+1774.4% | $3K |
| Total Equity | $23.0M-2.0% | $23.5M+10.8% | $21.2M-1.9% | $21.6M+10118.0% | $212K+122.2% | -$955K-29.8% | -$735K-1219.0% | -$56K+90.3% | -$573K-173.4% | -$210K+64.9% | -$597K-54.0% | -$388K-4927.0% | -$8K-110.9% | $70K-31.6% | $103K |
SBFM Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.6M+5.2% | $27.9M-4.3% | $30.1M-1.6% | $31.5M+4.8% | $32.0M+9.1% | $29.2M-8.5% | $30.6M+11.8% | $30.1M+8.7% | $29.3M+3.1% | $31.9M+18.2% | $27.3M-6.5% | $27.7M-32.3% |
| Total Liabilities | $6.1M-3.0% | $6.4M-1.1% | $7.0M-0.3% | $7.3M+45.3% | $6.3M+8.1% | $6.5M-8.4% | $7.1M+15.0% | $5.0M-11.8% | $5.8M+9.6% | $7.1M-6.4% | $6.1M-19.4% | $5.7M+1084.2% |
| Total Equity | $27.5M+7.2% | $21.5M-5.2% | $23.0M-2.0% | $24.2M-3.4% | $25.7M+9.3% | $22.7M-8.5% | $23.5M+10.8% | $25.0M+14.0% | $23.5M+1.6% | $24.8M+27.7% | $21.2M-1.9% | $22.0M-45.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Sunshine Biopharma Inc financials
Frequently Asked Questions
What was Sunshine Biopharma Inc's total assets in fiscal year 2025?
Sunshine Biopharma Inc closed fiscal year 2025 with $30.1M in total assets, $7.0M in total liabilities and $23.0M in shareholder equity.
How fast is Sunshine Biopharma Inc's total assets growing?
Sunshine Biopharma Inc (SBFM) total assets fell by 1.6% year over year, from $30.6M to $30.1M in fiscal year 2025.
How has Sunshine Biopharma Inc's total assets changed over the years?
Across the 15 fiscal years this page covers, Sunshine Biopharma Inc (SBFM) total assets went from $106K in fiscal year 2011 to $30.1M in fiscal year 2025.
What was Sunshine Biopharma Inc's total assets in the most recent quarter?
Sunshine Biopharma Inc (SBFM) reported $33.6M in total assets in Q2 2026. This represents an increase of 5.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Sunshine Biopharma Inc (SBFM) reported on that line in every period on record.